At Catalent Biologics, we understand the increasingly complex analytical and regulatory requirements for biologics and other large molecules and also new technologies and techniques that can be employed. We offer one of the broadest ranges of biologics and other large molecule analytical services in the industry, all under full CGMP compliance. Our biologics analytical services can be provided as a standalone service or integrated into development and manufacturing. We provide services for drug substance, drug product, and intermediates, both New Biologic Entities and Biosimilars/Biobetters and can provide support throughout the drug development pipeline, from pre-clinical testing through to post-approval release and stability. Through our experienced scientific team and range of capabilities, our goal is to serve as a strategic partner that can support all our customers’ analytical development and testing needs.